Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study

Por Schuette, Wolfgang, Schirmacher, Peter, Eberhardt, Wilfried E. E., Dietel, Manfred, Zirrgiebel, Ute, Muehlenhoff, Lars, Thomas, Michael
Publicado no BMC Cancer (2018)

ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3

Por Subramaniam, Srinivasa, Zirrgiebel, Ute, von Bohlen und Halbach, Oliver, Strelau, Jens, Laliberté, Christine, Kaplan, David R., Unsicker, Klaus
Publicado em 2004

Correction

Por Subramaniam, Srinivasa, Zirrgiebel, Ute, von Bohlen und Halbach, Oliver, Strelau, Jens, Laliberté, Christine, Kaplan, David R., Unsicker, Klaus
Publicado em 2004